[Effect of high selenium on insulin signaling pathway PI3K-AKT-mTOR in L02 cells]. 2024

Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

OBJECTIVE To observe the effect of high selenium on insulin signaling pathway PI3K-AKT-mTOR in L02 cells. METHODS One group of L02 cell was treated with different concentrations of selenomethionine(SeMet, 0.001, 0.0025, 0.005, 0.0075, 0.01, 0.025, 0.05, 0.075 and 0.1μmol/L) for 48 h, then cultured with serum-free medium for 4 h and stimulated with 1 μmol/L insulin for 15 min. The insulin signaling pathway(PI3K-AKT-mTOR) was detected by WB. Another group of L02 cell was treated with the same concentrations of SeMet as above for 48 h. The cell supernatant and lysates were collected for the analysis of SELENOP and GPX1, respectively by WB. RESULTS The expressions of P-AKT-(Ser-473), P-AKT-(Thr-308), PI3K and mTOR in L02 cells under high-Se were decreased with the increase of SeMet concentration. The expressions of GPX1 and SELENOP were enhanced with the increase of SeMet. CONCLUSIONS The insulin signaling pathway, PI3K-AKT-mTOR, was damaged in L02 cell under high-Se stress.

UI MeSH Term Description Entries

Related Publications

Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
September 2022, Pathology, research and practice,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
December 2014, American journal of cardiovascular drugs : drugs, devices, and other interventions,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
March 2019, Experimental and therapeutic medicine,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
February 2013, Zhongguo shi yan xue ye xue za zhi,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
October 2023, Genes,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
January 2015, Current molecular medicine,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
July 2021, Cancers,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
January 2012, Frontiers in immunology,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
July 2013, Bioorganic & medicinal chemistry,
Qin Wang, and Xue Zhang, and Jianrong Wang, and Yiqun Liu, and Feng Han, and Xuesong Xiang, and Yanbin Guo, and Zhenwu Huang
February 2022, Cellular and molecular biology (Noisy-le-Grand, France),
Copied contents to your clipboard!